Bills

AB 2760: Prescription drugs: prescribers: naloxone hydrochloride and other FDA-approved drugs.

  • Session Year: 2017-2018
  • House: Assembly
Version:

Existing law provides for the regulation of health care practitioners and requires prescription drugs to be ordered and dispensed in accordance with the Pharmacy Law. Existing law authorizes a pharmacist to furnish naloxone hydrochloride in accordance with standardized procedures or protocols developed by both the California State Board of Pharmacy and the Medical Board of California.

This bill would require a prescriber, as defined, to offer a prescription for naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression to a patient when certain conditions are present and to provide education on overdose prevention and the use of naloxone hydrochloride or another drug to the patient and specified others, except as specified. The bill would subject a prescriber to referral to the board charged with regulating his or her license for the imposition of administrative sanctions, as that board deems appropriate, for violating those provisions.

Discussed in Hearing

Assembly Floor1MIN
Aug 23, 2018

Assembly Floor

Senate Floor2MIN
Aug 20, 2018

Senate Floor

Senate Standing Committee on Business, Professions and Economic Development11MIN
Jun 18, 2018

Senate Standing Committee on Business, Professions and Economic Development

Assembly Floor3MIN
May 21, 2018

Assembly Floor

Assembly Standing Committee on Appropriations3MIN
May 16, 2018

Assembly Standing Committee on Appropriations

Assembly Standing Committee on Health4MIN
Apr 17, 2018

Assembly Standing Committee on Health

Assembly Standing Committee on Business and Professions5MIN
Apr 10, 2018

Assembly Standing Committee on Business and Professions

View Older Hearings

News Coverage:

AB 2760: Prescription drugs: prescribers: naloxone hydrochloride and other FDA-approved drugs. | Digital Democracy